COVID-19

Your central place to rapidly access latest news, translated guidance information, and expert interpretations from our former regulators related to COVID-19. Parexel’s 1000+ consulting experts are closely following agency announcements and new guidances and can help provide deep expertise and experience in the race to bring this outbreak to a close. We’re here to fight this with you.

  • COVID-19 weekly Health Authority updates

    COVID-19 weekly Health Authority updates

    Updated every day, in a single source

    View Now
  • The Special Approval Pathway (SAP) for COVID-19 related products in China

    The Special Approval Pathway (SAP) for COVID-19 related products in China

    The regulatory pathway for COVID-19 drugs in China is governed by the Special Approval Program (SAP) which was introduced by National Medical Product Administration (NMPA) in 2005.  SAP is...

    Learn More
  • See Parexel's latest COVID-19 expert content

    View all
  • Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Key Takeaways The COVID-19 pandemic has drawn attention to international efforts to promote...

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup October 26, 2020

    Coronavirus (COVID-19) Update: Daily Roundup October 26, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Visit Parexel's COVID 19 Clearinghouse

    Visit Now
  • The World Health Organization and Wikimedia Foundation expand access to trusted information about COVID-19 on Wikipedia

    The World Health Organization and Wikimedia Foundation expand access to trusted information about COVID-19 on Wikipedia

    The World Health Organization (WHO) and the Wikimedia Foundation, the nonprofit that administers Wikipedia, announced today a collaboration to expand the public’s access to the latest and most...

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020

    Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020

    Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Drug Development for Rare Disease and Oncology During the COVID-19 Pandemic

    Drug Development for Rare Disease and Oncology During the COVID-19 Pandemic

    Learn More
  • Strengthening global collaboration on COVID-19 real-world evidence and observational studies, , 23/10/2020

    Medicines regulators from around the world discussed their experiences with supporting and assessing real-world evidence to facilitate regulatory...

    Learn More
  • Nigeria resumes Yellow fever vaccination with safety measures necessary for the COVID-19 context

    You can access the original press release by clicking here.  

    Learn More
  • Lupus Anticoagulant in Patients with Covid-19

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Facial Masking for Covid-19

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • FDA Approves First Treatment for COVID-19

    FDA Approves First Treatment for COVID-19

    FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. Veklury is the first...

    Learn More
  • FDA’s approval of Veklury (remdesivir) for the treatment of COVID-19—The Science of Safety and Effectiveness

    FDA’s approval of Veklury (remdesivir) for the treatment of COVID-19—The Science of Safety and Effectiveness

    FDA recognizes that patients affected by coronavirus 2019 (COVID-19) are in great need of medicines to treat this disease. To help meet this need, the agency is helping to speed the development of...

    Learn More
  • FDA Approves First Treatment for COVID-19

    FDA Approves First Treatment for COVID-19

    FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. Veklury is the first...

    Learn More
  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Covid-19 Vaccine Trials and Incarcerated People — The Ethics of Inclusion

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Anticoagulation in Hospitalized Patients with Covid-19

    New England Journal of Medicine, Volume 383, Issue 17, Page 1675-1678, October 2020.

    Learn More
  • Audio Interview: Tocilizumab and Covid-19

    New England Journal of Medicine, Volume 383, Issue 17, October 2020.

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup October 20, 2020

    Coronavirus (COVID-19) Update: Daily Roundup October 20, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • loading
    Loading More...